Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe ...

In a groundbreaking discovery, scientists have found that the birth of new brain cells in adults plays a key role in verbal ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Mar. 25, 2025 — A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers. If the drug proves viable for human ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, ...

Professor John Duncan, Corresponding Author, UCL Queen Square Institute of Neurology In the first study of its kind, the researchers examined 84 people with temporal lobe epilepsy (epilepsy ...

In the first study of its kind, the researchers examined 84 people with temporal lobe epilepsy (epilepsy arising from the temporal lobe at the sides of the head) and hippocampal sclerosis (a ...

More information: Giorgio Fiore et al, Cortico-hippocampal networks underpin verbal memory encoding in temporal lobe epilepsy, Brain Communications (2025). DOI: 10.1093/braincomms/fcaf067 Journal ...